PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Progenics Pharmaceuticals, Inc.'s quarterly common stock increased from Jun. 2013 ($0.08 Mil) to Sep. 2013 ($0.08 Mil) but then stayed the same from Sep. 2013 ($0.08 Mil) to Dec. 2013 ($0.08 Mil).
Progenics Pharmaceuticals, Inc.'s annual common stock increased from Dec. 2011 ($0.04 Mil) to Dec. 2012 ($0.06 Mil) and increased from Dec. 2012 ($0.06 Mil) to Dec. 2013 ($0.08 Mil).
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
Progenics Pharmaceuticals, Inc. Annual Data
Progenics Pharmaceuticals, Inc. Quarterly Data